NGS Data Analysis Market

NGS Data Analysis Market Analysis Report By Service Type (Whole-Genome, Exome, RNA, ChIP Sequencing), By Technique (SBS, SMRT, Ion semiconductor sequencing), By End User & By Region - Global Market Insights 2022-2032

Analysis of NGS Data Analysis market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

NGS Data Analysis Market Outlook (2022-2032)

The global NGS data analysis market is set to enjoy a valuation of US$ 561.4 Million in 2022 and further expand at a CAGR of 15.2% to reach US$ 2,314.7 Million by the end of 2032.

The global NGS data analysis market is dominated by North America, which is predicted to grow the market by nearly 40% throughout the evaluation period.

Report Attributes


NGS Data Analysis Market Size (2021A)

US$ 488.8 Million

Estimated Market Value (2022E)

US$ 561.4 Million

Forecasted Market Value (2032F)

US$ 2,314.7 Million

Global Market Growth Rate (2022-2032)

~15.2% CAGR

North America Market Share (2021)


East Asia Market Growth Rate (2022-2032)

~19.5% CAGR

United States Market Growth Rate (2022-2032)

~16.8% CAGR

Market Share of Top 5 Companies


Key Companies Profiled

  • ABM Inc.
  • Agilent Technologies
  • Biomatters Ltd
  • DNAnexus
  • Dovetail Genomics LLC
  • Edge Biosystems
  • Genestack
  • Illumina
  • Roche

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Sales Analysis of NGS Data Analysis (2017-2021) Vs. Market Forecast Outlook (2022-2032)

Rigorous technological advancements in the field of data generation, integration, storage and access along with cloud computing solutions had a significant impact in overcoming data-handling constraints, which require evaluating enormous amounts of high-throughput sequence data.

In comparison to early practices of data storage in the form of physical written files cloud storage has been a boon to the sequence analysis industry. However, aforementioned pertaining issues stages a platform for potential research and development opportunities for the providers, hence will lead to market growth.

Next-generation sequencing (NGS) has greatly aided in the investigation of epigenetics and genomic patterns linked with numerous biological processes. The inevitable need for NGS data analysis primarily in almost every research and development domain has garnered the market with a compound annual growth rate of 15.2% over 2022-2032.

The instant raise in demand of sequence analysis tools for precise interpretation of short or long, single or multiple, genomic, protein or amino acid sequences has up-surged the use of NGS data analysis tools. Next-generation sequencing technology enables in-depth analysis of biological systems by researchers because of its unmatched throughput, speed, and scalability.

Compared to what is offered by traditional DNA sequencing techniques, the complexity of genomic research demands a higher level of comprehension. Next-generation sequencing has become a regular research methodology in order to address these expectations.

When interpreting NGS data, cloud-based platforms provide advantageous options for activities that necessitate a lot of computing. As a result, it is now simple and quick to acquire the necessary computing power to carry out large-scale NGS data processing. Under the supremacy of these factors, the NGS data analysis market is expected to offer an absolute $ opportunity of US$ 1,825.8 Million over 2022 to 2032.

  • Short Term (2022 Q2 to 2025): The present need for augmentation and utilization of advanced data sequencing in the healthcare and research industry owing to the present demands of genetics based approaches for health impairment treatments will positively impact NGS data analysis market growth with an absolute $ opportunity of US$ 359.5 Million in the short term period of 2022-2025.
  • Medium Term (2025-2028): Burgeoning expansion of healthcare and research industries in the low economic regions such as East Asia, Middle East and Africa will open plethora of opportunities for the next generation sequencing service providers and software developers. Increase in per capita healthcare spending and adoption of vast sequencing projects such as whole genome sequencing of every individual will drive the market.
  • Long Term (2028-2032): The increase in demand for personalized diagnosis systems and medication of various ailments in nearing future will be acceptable as a global trend. Moreover, emergence of global pandemic such as COVID-19 and raise in chronic diseases will have an exponential impact on market growth. The global NGS data analysis market is predicted to grow at a healthy Y-o-Y of 15.9% over 2031- 2032.

Over the 2017-2021 historical period, the global NGS data analysis market registered a CAGR of 13.7% and according to the Fact.MR, a market research and competitive intelligence provider, the market is projected to exhibit growth at of 15.2% CAGR between 2022 and 2032.

Global NGS data analysis market forecast by Fact.MR

Market share analysis of NGS data analysis based on end users and region is provided in a nutshell in the above image. Under the end users segment, the diagnostic laboratories sub-segment will dominate with 19.6% market share in 2022.

What’s Driving Demand for NGS Data Analysis?

“Increased Prevalence of Personalized Medications to Uplift the Market.”

The advancement of next-generation sequencing (NGS) technologies and their expanding application in clinical diagnosis, genomic research, and personalized medicine for a variety of diseases are increasing the demand for precise and speedy sequencing interpretation tools and algorithms that can accelerate data analysis.

NGS protocols have been explicitly used for oncology precise medicine, particularly for breast and lung tumors. Genetic research such as the detection of somatic driver mutations, germline mutations, resistance mutations, tumor genotyping, and quantification of mutational load can be carried out with the advent of improved algorithms and software in next generation sequencing. Additionally, these developments have laid a new foundation for treating cancer-related illnesses.

“Increasing Next Generation Sequencing Projects in Government and Private Research Firms.”

The effective and accurate study of genomic and epigenomic motif which incorporates enormous biological processes has been simplified with the advent of next generation sequencing. Escalated investments in scientific research and development both by government and private agencies will scale up the opportunities for cumulative market growth.

Additionally, it is projected that sequencing projects would grow in scale due to the massive output of genetic data and concomitant drop in sequencing costs. As a result, sophisticated, practical bioinformatics pipelines are now more necessary than ever.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What Do NGS Data Analysis Providers Need to Watch Out for?

“High infrastructural costs and inadequate number of skilled professionals to restrain market’s growth.”

Advent of technology comes along with a disturbing financial irregularity. Though NGS data analysis have solved much of the research and developmental problems, there are many factors restraining the market growth. The high-setup costs of the software and algorithms will tend to suppress the market growth in present times.

The expense of the premium next-generation sequencing devices, including installation, upkeep, reagents, and output analysis, might surpass millions of dollars. The majority of responders advocated sequencing as a service rather than an investment in internal research.

Alongside, many healthcare professionals are unaware about the technological advents. Due less number of professionally skilled technology operators from the end users side, the market faces challenging constrains.

Country-wise Insights

Why Will North America Experience a Lucrative Growth and High Demand in The NGS Data Analysis Sector?

North America lodges most of the market dominators in the sector of NGS data analysis. With a large section of government investment on healthcare research and development, North America dominates the market of NGS data analysis.

High concentrated research on development of target specific and personalized drugs in the region has staged opportunities for the organizations and service providers in the region. Owing to the aforementioned factors the North American region is poised to grow at a healthy CAGR of 17.1% over the forecasted period of 2022-2032.

How The Rising Per Capita Disposable Incomes in The Under-Developed Regions Will Affect the Demand for NGS Data Analysis Market?

Rigorous investment in understanding the healthcare concerns in the under-developed regions such as East Asia will propel the NGS data analysis market in due period of time over the projected period, East Asia is anticipated to develop at the fastest rate.

The adoption of sequencing technologies in Japan has significantly advanced our understanding of the molecular causes of cancer. Numerous cancer gene panels based on NGS technology have received approval from the Japanese Ministry of Health, Labor, and Welfare for use in clinical settings. East Asia will contribute to hold a value share of 19.5% of overall market in 2022.

Category-wise Insights

Why Do Services Sector Dominates the NGS Data Analysis Market?

NGS technologies have become increasingly used in clinical diagnosis, individualized therapy of various illnesses, and genomics research since they first became available. Services like whole-genome sequencing, exome sequencing, targeted resequencing, de novo sequencing, RNA sequencing, chip sequencing, methyl sequencing and various other are being rigorously used to identify the molecular level root cause of disorders and diseases.

NGS can also be done at the transcriptome level, which necessitates integrating all of the Rna in a particular cell type, including the mRNA, rRNA, tRNA, micro-RNA, and non-coding RNA. The sub-segment exome sequencing dominates the overall service type segment holding a share of 31.6% in 2021.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Competitive Landscape

Reowned NGS data analysis providers ABM Inc., Agilent Technologies, Biomatters Ltd, DNAnexus, Dovetail Genomics LLC, Edge Biosystems, Genestack, Illumina, Roche.

Additionally, the businesses are using these surveillance platforms, which can offer a reliable platform for virus sequencing and analysis. Similar to this, different industry players are looking for businesses that provide affordable solutions. In order to grow their operations, companies are also concentrating on creating affordable genome sequencing options. For example, Phase Genomics announced in October 2021 that it would introduce a cost-effective platform for genomic analysis.

Segmentation of NGS Data Analysis Industry Research

  • By Service Type :

    • Whole-Genome Sequencing
    • Exome Sequencing
    • Targeted Resequencing
    • De Novo Sequencing
    • RNA Sequencing
    • ChIP Sequencing
    • Methyl Sequencing
    • Other Services
  • By Technique :

    • Sequencing by Synthesis (SBS) Technology
    • Real-Time (SMRT) Technology
    • Ion semiconductor sequencing Technology
    • Others
  • By End-User :

    • Hospitals
    • Academic Research Institutes
    • Biotechnology/Pharmaceutical Companies
    • Contract Research Organization
    • Other End Users
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & ASEAN
    • Oceania
    • MEA

- FAQs -

The global NGS data analysis market is valued at US$ 561.4 Million in 2022.

Worldwide demand for NGS data analysis is anticipated to reach US$ 2,314.7 Million by 2032-end.

During 2017-2021, sales of NGS data analysis increased at 13.7% CAGR.

North America tops the global NGS data analysis market accounting for 39.6% market share in 2021.

Exome Sequencing account for 82.5% share of global s NGS data analysis sales in 2021.

NGS Data Analysis Market

Schedule a Call

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.

By clicking "Accept All", you consent to our use of cookies. Privacy Policy